Sort
64,565 grants matching “drug discovery”
Drug repurposing for Alzheimer's disease using structural systems pharmacology
$770,770Lei Xie · Hunter College · R56 · FY2017 · AG
Administrative Core
$770,733John C Reed · Sanford Burnham Prebys Medical Discovery Institute · U54 · FY2011 · HG
Development of IMPDH-Targeted Drugs against Crytosporidium
$770,714Lizbeth K. Hedstrom · Brandeis University · U01 · FY2008 · AI
CSUMS: NC State University Computation for Undergraduates in Statistics Program (NCSU CUSP)
$770,714Brian J Reich · North Carolina State University · · FY2007 · MPS
Subtype-Selective Metabotropic Glutamate Receptor PET Ligands
$770,694Steven H Liang · Emory University · R61 · FY2024 · NS
Identification of Novel Small Molecules as Tau Protein Aggregation Inhibitors for
$770,675Alan D. Snow · Proteotech, Inc. · R43 · FY2011 · AG
GENETICS OF ADOLESCENT ANTISOCIAL DRUG DEPENDENCE
$770,614University Of Colorado Denver · R01 · FY2001 · DA
The Plasmodial Surface Anion Channel And Malaria Parasite Nutrient Acquisition
$770,613Sanjay A Desai · National Institute Of Allergy And Infectious Diseases · ZIA · FY2011 · AI
Discovery of Phospopantetheinyl Transferse Inhibitors Against Mycobacterium tuberculosis
$770,597Jeffrey Aube · Univ Of North Carolina Chapel Hill · R01 · FY2024 · AI
Spore germination pathway in Clostridioides difficile and its pharmacological intervention
$770,512Mayland F Chang · University Of Notre Dame · R01 · FY2024 · AI
Biophotonics
$770,484George Patterson · National Institute Of Biomedical Imaging And Bioengineering · ZIA · FY2021 · EB
Small Molecule Inhibitors of Ebola Virus Polymerase Function
$770,311Christopher F Basler · Icahn School Of Medicine At Mount Sinai · R01 · FY2021 · AI
Integrative genomic and functional genomic studies to connect variant to function for CAD GWAS loci
$770,223Hanrui Zhang · Columbia University Health Sciences · R01 · FY2025 · HL
A Scalable Platform to Discover Antimicrobials of Ribosomal Origin
$770,174Huimin Zhao · University Of Illinois At Urbana-Champaign · R01 · FY2022 · AI
A Scalable Platform to Discover Antimicrobials of Ribosomal Origin
$770,174Huimin Zhao · University Of Illinois At Urbana-Champaign · R01 · FY2023 · AI
MANIPULATING IKS AS A THERAPEUTIC APPROACH TO CARDIAC ARRHYTHMIAS
$770,164Jianmin Cui · Washington University · R01 · FY2018 · HL
MANIPULATING IKS AS A THERAPEUTIC APPROACH TO CARDIAC ARRHYTHMIAS
$770,164Jianmin Cui · Washington University · R01 · FY2016 · HL
MANIPULATING IKS AS A THERAPEUTIC APPROACH TO CARDIAC ARRHYTHMIAS
$770,164Jianmin Cui · Washington University · R01 · FY2017 · HL
Primity Cloud: High-Performance Cytometry Analysis Engine
$770,102Peter Krutzik · Primity, Inc. · R44 · FY2018 · AI
Development of an Advanced In-Vitro Model for Angiogenesis Research and Drug Test
$770,090Thomas Neumann · Nortis, Inc. · R44 · FY2014 · HL
Targeted Inhibition of Interleukin-1 beta to Prevent Preterm Birth
$770,043Kristina M Adams Waldorf · University Of Washington · R01 · FY2021 · HD
Calprotectin and Antibiotic Activities at the Infection Interface
$770,037Brian Patrick Conlon · Univ Of North Carolina Chapel Hill · R01 · FY2025 · AI
CAREER: Synthesis and Applications of Multipurpose Halomucononitrile Linchpin Reagents
$770,000Sidney M Wilkerson-Hill · University Of North Carolina At Chapel Hill · · FY2023 · MPS
Target based discovery of next generation pyrazinamide
$769,649Veronique Dartois · Rbhs-New Jersey Medical School · R01 · FY2018 · AI
Sialoglycoproteomic network and target discovery for Alzheimer's disease
$769,621Lian Li · Emory University · R01 · FY2024 · AG